Serologic Response to Hepatitis B Vaccination in HIV‐Infected Patients with Isolated Positivity for Antibodies to Hepatitis B Core Antigen

Abstract

We assessed the safety and immunogenicity of hepatitis B vaccination among 40 human immunodeficiency virus-infected patients with isolated positivity for antibodies to hepatitis B core antigen. No baseline factors were found to be predictive of an anamnestic response, which occurred in 32.5% of the patients. The overall response rate among patients without an anamnestic response was 74.0% after 3-6 vaccine doses.